Palantir Technologies announced a partnership with Onemednet Corp to utilize Palantir's Artificial Intelligence Platform (AIP) to improve healthcare AI and data analytics capabilities. This multi-year agreement will see Palantir's software provide the infrastructure for OneMedNet's AI-powered network, which aggregates real-world imaging data for clinical research. The collaboration aims to accelerate the use of this data across numerous provider sites, covering areas like oncology and cardiology. This move deepens Palantir's presence in the healthcare and life sciences industry, building on existing collaborations with the FDA and NIH. Separately, on the same day, a partnership was announced with Hertz Global Holdings to deploy AI-driven solutions for fleet and workforce management. In terms of market analysis, one report noted that while Palantir's stock has seen significant growth in 2025, it has been consolidating recently ahead of its earnings report scheduled for November 3. The same report pointed to bullish options activity, suggesting some traders are positioning for potential upside momentum.